Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-43874
Eur J Med Chem 2015 Apr 13;94:237-51. doi: 10.1016/j.ejmech.2015.02.051.
Show Gene links Show Anatomy links

A facile synthesis and microtubule-destabilizing properties of 4-(1H-benzo[d]imidazol-2-yl)-furazan-3-amines.

Stepanov AI , Astrat'ev AA , Sheremetev AB , Lagutina NK , Palysaeva NV , Tyurin AY , Aleksandrova NS , Sadchikova NP , Suponitsky KY , Atamanenko OP , Konyushkin LD , Semenov RV , Firgang SI , Kiselyov AS , Semenova MN , Semenov VV .


???displayArticle.abstract???
A series of 4-(1H-benzo[d]imidazol-2-yl)-furazan-3-amines (BIFAs) were prepared in good yields (60-90% for each reaction step) via a novel procedure from aminofurazanyl hydroximoyl chlorides and o-diaminobenzenes. The synthetic sequence was run under mild reaction conditions, it was robust and did not require extensive purification of intermediates or final products. Furthermore, there was no need for protection of reactive moieties allowing for the parallel synthesis of diverse BIFA derivatives. Subsequent biological evaluation of the resulting compounds revealed their anti-proliferative effects in the sea urchin embryo model and in cultured human cancer cell lines. The most active compounds showed 0.2-2 μM activities in both assay systems. The unsubstituted benzene ring of the benzoimidazole template as well as the unsubstituted amino group in the furazan ring were essential prerequisites for the antimitotic activity of BIFAs. Compound 57 bearing the 2-chlorophenyl acetamide substituent at the nitrogen atom of the imidazole ring was the most active molecule in the examined set.

???displayArticle.pubmedLink??? 25768706
???displayArticle.link??? Eur J Med Chem


Genes referenced: LOC100887844 LOC100893907 LOC115919910 LOC583082